{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19 main protease", "inhibition", "medicinal plants", "meta-analysis", "systematic review"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36651508", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "19"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.2478/acph-2022-0021"], "Journal": {"ISSN": "1846-9558", "JournalIssue": {"Volume": "72", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "01"}}, "Title": "Acta pharmaceutica (Zagreb, Croatia)", "ISOAbbreviation": "Acta Pharm"}, "ArticleTitle": "Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis.", "Pagination": {"StartPage": "199", "EndPage": "224", "MedlinePgn": "199-224"}, "Abstract": {"AbstractText": ["The novel SARS-CoV-2 (severe acute respiratory syndrome coronavirus) has emerged as a significant threat to public health with startling drawbacks in all sectors globally. This study investigates the practicality of some medicinal plants for SARS-CoV-2 therapy using a systematic review and meta-analysis of their reported SARS-CoV-1 inhibitory potencies. Relevant data were systematically gathered from three databases, <i>viz.</i>, Web of Science, PubMed and Scopus. The information obtained included botanical information, extraction method and extracts concentrations, as well as the proposed mechanisms. Fourteen articles describing 30 different plants met our eligibility criteria. Random effects model and subgroup analysis were applied to investigate heterogeneity. According to subgroup analysis, the substantial heterogeneity of the estimated mean based on the <i>IC</i> <sub>50</sub> values reporting the most potent anti-SARS-CoV 3C--like protease (3CLpro) inhibitors (10.07 %, <i>p</i> < 0.0001), was significantly higher compared to the most active anti-SARS-CoV papain-like protease (PLpro) inhibitors (6.12 %, <i>p</i> < 0.0001). More importantly, the literature analysis revealed that fruit extracts of <i>Rheum palmatum</i> L. and the compound cryptotanshinone isolated from the root of <i>Salvia miltiorrhiza</i> (<i>IC</i> <sub>50</sub> = 0.8 \u00b1 0.2 \u03bcmol L<sup>-1</sup>) were excellent candidates for anti--SARS-CoV targeting PLpro. Meanwhile, iguesterin (<i>IC</i> <sub>50</sub> = 2.6 \u00b1 0.6 \u03bcmol L<sup>-1</sup>) isolated from the bark of <i>Tripterygium regelii</i> emerged as the most excellent candidate for anti-SARS--CoV targeting 3CLpro. The present systematic review and meta-analysis provide valuable and comprehensive information about potential medicinal plants for SARS-CoV-2 inhibition. The chemotypes identified herein can be adopted as a starting point for developing new drugs to contain the novel virus."], "CopyrightInformation": "\u00a9 2022 Oluwakemi Ebenezer., published by Sciendo."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1Faculty of Natural Science, Department of Chemistry, Mangosuthu University of Technology, 511 Mangosuthu Highway Durban, 4000, South Africa."}], "LastName": "Ebenezer", "ForeName": "Oluwakemi", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "2Department of Agriculture and Animal Health, University of South Africa Florida Campus, Florida, 1710 South Africa."}], "LastName": "Bodede", "ForeName": "Olusola", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "3School of Chemistry and Physics University of KwaZulu-Natal P/Bag X54001, Westville, Durban South Africa."}], "LastName": "Awolade", "ForeName": "Paul", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1Faculty of Natural Science, Department of Chemistry, Mangosuthu University of Technology, 511 Mangosuthu Highway Durban, 4000, South Africa."}], "LastName": "Jordaan", "ForeName": "Maryam A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "4Discipline of Public Health Medicine College of Health Sciences University of KwaZulu Natal, Durban 4001, South Africa."}], "LastName": "Ogunsakin", "ForeName": "Ropo E", "Initials": "RE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1Faculty of Natural Science, Department of Chemistry, Mangosuthu University of Technology, 511 Mangosuthu Highway Durban, 4000, South Africa."}], "LastName": "Shapi", "ForeName": "Michael", "Initials": "M"}], "PublicationTypeList": ["Meta-Analysis", "Systematic Review", "Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Poland", "MedlineTA": "Acta Pharm", "NlmUniqueID": "9303678", "ISSNLinking": "1330-0075"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Drug Repositioning"}, {"QualifierName": [], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "F. Wu, S. Zhao, B. Yu, Y. M. Chen, W. Wang, Z. G. Song, Y. Hu, Z. W. Tao, J. H. Tian, Y. Y. Pei, M. L. Yuan, Y. L. Zhang, F. H. Dai, Y. Liu, Q. M. Wang, J. J. Zheng, L. Xu, E. C. Holmes and Y. Z. Zhang, A new coronavirus associated with human respiratory disease in China, Nature 579 (2020) 265\u2013269; https://doi.org/10.1038/s41586-020-2008-310.1038/s41586-020-2008-3"}, {"Citation": "X. Xu, P. Chen, J. Wang, J. Feng, H. Zhou, X. Li, W. Zhong and P. Hao, Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission, Sci. China Life Sci. 63 (2020) 457\u2013460; https://doi.org/10.1007/s11427-020-1637-510.1007/s11427-020-1637-5"}, {"Citation": "A. J. Rodr\u00edguez-Morales, K. MacGregor, S. Kanagarajah, D. Patel and P. Schlagenhauf, Going global \u2013 Travel and the 2019 novel coronavirus, Travel Med. Infect. Dis. 33 (2020) 101578; https://doi.org/10.1016/j.tmaid.2020.10157810.1016/j.tmaid.2020.101578"}, {"Citation": "C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang and B. Cao, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet 395 (2020) 497\u2013506; https://doi.org/10.1016/S0140-6736"}, {"Citation": "E. Prompetchara, C. Ketloy and T. Palaga, Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic, Asian Pac. J. Allergy Immunol. 38 (2020) 1\u20139; https://doi.org/10.12932/AP-200220-077210.12932/AP-200220-0772"}, {"Citation": "X. Yang, Y. Yu, J. Xu, H. Shu, J. Xia, H. Liu, Y. Wu, L. Zhang, Z. Yu, M. Fang, T. Yu, Y. Wang, S. Pan, X. Zou, S. Yuan and Y. Shang, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study, Lancet Respir. Med. 8 (2020) 475\u2013481; https://doi.org/10.1016/S2213-2600(20)30079-510.1016/S2213-2600(20)30079-5"}, {"Citation": "F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu, J. Xiang, Y. Wang, B. Song, X. Gu, L. Guan, Y. Wei, H. Li, X. Wu, J. Xu, S. Tu, Y. Zhang, H. Chen and B. Cao, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study, Lancet 395 (2020) 1054\u20131062; https://doi.org/10.1016/S0140-6736(20)30566-310.1016/S0140-6736(20)30566-3"}, {"Citation": "Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2, Nat. Microbiol. 5 (2020) 536\u2013544; https://doi.org/10.1038/s41564-020-0695-z10.1038/s41564-020-0695-z709544832123347"}, {"Citation": "J. S. Rest and D. P. Mindell, SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting, Infect. Genet. Evol. 3 (2003) 219\u2013225; https://doi.org/10.1016/j.meegid.2003.08.00110.1016/j.meegid.2003.08.001712987814522185"}, {"Citation": "C. C. Hon, T. Y. Lam, Z. L. Shi, A. J. Drummond, C. W. Yip, F. Zeng, P. Y. Lam and F. C. Leung, Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus, J. Virol. 82 (2008) 1819\u20131826; https://doi.org/10.1128/JVI.01926-0710.1128/JVI.01926-07225872418057240"}, {"Citation": "D. Schoeman and B. C. Fielding, Coronavirus envelope protein: current knowledge, Virol. J. 16 (2019) Article ID 69 (22 pages); https://doi.org/10.1186/s12985-019-1182-010.1186/s12985-019-1182-0653727931133031"}, {"Citation": "P. Zhou, X. L. Yang, X. G. Wang, B. Hu, L. Zhang, W. Zhang, H. R. Si, Y. Zhu, B. Li, C. L. Huang, H. D. Chen, J. Chen, Y. Luo, H. Guo, R. D. Jiang, M. Q. Liu, Y. Chen, X. R. Shen, X. Wang, X. S. Zheng, K. Zhao, Q. J. Chen, F. Deng, L. L. Liu, B. Yan, F. X. Zhan, Y. Y. Wang, G. F. Xiao and Z. L. Shi, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature 579 (2020) 270\u2013273; https://doi.org/10.1038/s41586-020-2012-710.1038/s41586-020-2012-7"}, {"Citation": "R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, N. Zhu, Y. Bi, X. Ma, F. Zhan, L. Wang, T. Hu, H. Zhou, Z. Hu, W. Zhou, L. Zhao, J. Chen, Y. Meng, J. Wang, Y. Lin, J. Yuan, Z. Xie, J. Ma, W. J. Liu, D. Wang, W. Xu, E. C. Holmes, G. F. Gao, G. Wu, W. Chen, W. Shi and W. Tan, Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding, Lancet 395 (2020) 565\u2013574; https://doi.org/10.1016/S0140-6736(20)30251-810.1016/S0140-6736(20)30251-8"}, {"Citation": "K. Anand, J. Ziebuhr, P. Wadhwani, J. R. Mesters and R. Hilgenfeld, Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs, Science 300 (2003) 1763\u20131767; https://doi.org/10.1126/science.108565810.1126/science.1085658"}, {"Citation": "M. T. ul Qamar, S. M. Alqahtani, M. A. Alamri and L. L. Chen, Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants, J. Pharm. Anal. 10 (2020) 313\u2013319; https://doi.org/10.1016/j.jpha.2020.03.00910.1016/j.jpha.2020.03.009"}, {"Citation": "A. L. Totura and R. S. Baric, SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon, Curr. Opin. Virol. 3 (2012) 264\u2013275; https://doi.org/10.1016/j.coviro.2012.04.00410.1016/j.coviro.2012.04.004"}, {"Citation": "T. H. Mogensen and S. R. Paludan, Molecular pathways in virus-induced cytokine production, Microbiol. Mol. Biol. Rev. 65 (2001) 131\u2013150; https://doi.org/10.1128/MMBR.65.1.131-150.200110.1128/MMBR.65.1.131-150.2001"}, {"Citation": "C. K. Wong, C. W. Lam, A. K. Wu, W. K. Ip, N. L. Lee, I. H. Chan, L. C. Lit, D. S. Hui, M. H. Chan, S. S. Chung and J. J. Sung, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin. Exp. Immunol. 136 (2004) 95\u2013103; https://doi.org/10.1111/j.1365-2249.2004.02415.x10.1111/j.1365-2249.2004.02415.x"}, {"Citation": "O. Ebenezer, M. A. Jordaan, R. E. Ogunsakin and M. Shapi, Potential SARS-COV preclinical (in vivo) compounds targeting COVID-19 main protease: A meta-analysis and molecular docking studies, Hippokratia 24 (2020) 99\u2013106."}, {"Citation": "K. Van Reeth, S. Van Gucht and M. Pensaert, In vivo studies on cytokine involvement during acute viral respiratory disease of swine: Troublesome but rewarding, Vet. Immunol. Immunopathol. 87 (2002) 161\u2013168; https://doi.org/10.1016/s0165-2427(02)00047-810.1016/S0165-2427(02)00047-8"}, {"Citation": "C. Y. Cheung, L. L. Poon, A. S. Lau, W. Luk, Y. L. Lau, K. F. Shortridge, S. Gordon, Y. Guan and J. S. Peiris, Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease?, Lancet 360 (2002) 1831\u20131837; https://doi.org/10.1016/s0140-6736(02)11772-710.1016/S0140-6736(02)11772-7"}, {"Citation": "L. Zhang, D. Lin, X. Sun, U. Curth, C. Drosten, L. Sauerhering, S. Becker, X. Rox and R. Hilgenfeld, Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors, Science 368 (2020) 409\u2013412; https://doi.org/10.1126/science.abb340510.1126/science.abb3405716451832198291"}, {"Citation": "R. Hilgenfeld, From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design, FEBS J. 281 (2014) 4085\u20134096; https://doi.org/10.1111/febs.1293610.1111/febs.12936"}, {"Citation": "S. Y. Li, C. Chen, H. Q. Zhang, H. Y. Guo, H. Wang, L. Wang, X. Zhang, S. N. Hua, J. Yu, P. G. Xiao, R. S. Li and X. Tan, Identification of natural compounds with antiviral activities against SARS-associated coronavirus, Antiviral. Res. 67 (2005) 18\u201323; https://doi.org/10.1016/j.antiviral.2005.02.00710.1016/j.antiviral.2005.02.007"}, {"Citation": "C. C. Wen, Y. H. Kuo, J. T. Jan, P. H. Liang, S. Y. Wang, H. G. Liu, C. K. Lee, S. T. Chang, C. J. Kuo, S. S. Lee, C. C. Hou, P. W. Hsiao, S. C. Chien, L. F. Shyur and N. S. Yang, Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus, J. Med. Chem. 50 (2007) 4087\u20134095; https://doi.org/10.1021/jm070295s10.1021/jm070295s"}, {"Citation": "L. T. Lin, W. C. Hsu and C. C. Lin, Antiviral natural products and herbal medicines, J. Tradit. Complement. Med. 4 (2014) 24\u201335; https://doi.org/10.4103/2225-4110.12433510.4103/2225-4110.124335"}, {"Citation": "T. Pillaiyar, M. Manickam, V. Namasivayam, Y. Hayashi and S. H. Jung, An Overview of severe acute respiratory syndrome-Coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy, J. Med. Chem. 59 (2016) 6595\u20136628; https://doi.org/10.1021/acs.jmedchem.5b0146110.1021/acs.jmedchem.5b01461"}, {"Citation": "L. Shamseer, D. Moher, M. Clarke, D. Ghersi, A. Liberati, M. Petticrew, P. Shekelle and L. A. Stewart, (PRISMA-P group), Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation, BMJ 350 (2015) Article ID g7647; https://doi.org/10.1136/bmj.g764710.1136/bmj.g7647"}, {"Citation": "W. Yan, K. Ohtani, R. Kasai and K. Yamasaki, Steroidal saponins from fruits of Tribulus terrestris, Phytochemistry 42 (1996) 1417\u20131422; https://doi.org/10.1016/0031-9422(96)00131-810.1016/0031-9422(96)00131-8"}, {"Citation": "I. Kostova and D. Dinchev, Saponins in Tribulus terrestris \u2013 Chemistry and bioactivity, Phytochem. Rev. 4 (2005) 111\u2013137; https://doi.org/10.1007/s11101-005-2833-x10.1007/s11101-005-2833-x"}, {"Citation": "N. Mulinacci, P. Vignolini, G. la Marca, G. Pieraccini, M. Innocenti and F. F. Vincieri, Food supplements of Tribulus terrestris L.: An HPLC-ESI-MS method for an estimation of the saponin content, Chromatographia 57 (2003) 581\u2013592; https://doi.org/10.1007/BF0249173310.1007/BF02491733"}, {"Citation": "W. Zheng, F. Wang, Y. Zhao, X. Sun, L. Kang, Z. Fan, L. Qiao, R. Yan, S. Liu and B. Ma, Rapid characterization of constituents in Tribulus terrestris from different habitats by UHPLC/Q-TOF MS, J. Am. Soc. Mass Spectrom. 28 (2017) 2302\u20132318; https://doi.org/10.1007/s13361-017-1761-510.1007/s13361-017-1761-528766114"}, {"Citation": "C. Tian, Z. Zhang, H. Wang, Y. Guo, J. Zhao and M. Liu, Extraction technology, component analysis, and in vitro antioxidant and antibacterial activities of total flavonoids and fatty acids from Tribulus terrestris L. fruits, Biomed. Chromatogr. 33 (2019) e4474; https://doi.org/10.1002/bmc.447410.1002/bmc.447430577068"}, {"Citation": "J. Kaushik, S. Tandon, R. Bhardwaj, T. Kaur, S. K. Singla, J. Kumar and C. Tandon, Delving into the antiurolithiatic potential of Tribulus terrestris extract through \u2013 In vivo efficacy and preclinical safety investigations in Wistar rats, Sci. Rep. 9 (2019) Article ID 15969 (13 pages); https://doi.org/10.1038/s41598-019-52398-w10.1038/s41598-019-52398-w682897031685914"}, {"Citation": "Y. H. Song, D. W. Kim, M. J. Curtis-Long, H. J. Yuk, Y. Wang, N. Zhuang, K. H. Lee, K. S. Jeon and K. H. Park, Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits, Biol. Pharm. Bull. 37 (2014) 1021\u20131028; https://doi.org/10.1248/bpb.b14-0002610.1248/bpb.b14-0002624882413"}, {"Citation": "C. W. Lin, F. J. Tsai, C. H. Tsai, C. C. Lai, L. Wan, T. Y. Ho, C. C. Hsieh and P. D. Chao, Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds, Antiviral Res. 68 (2005) 36\u201342; https://doi.org/10.1016/j.antiviral.2005.07.00210.1016/j.antiviral.2005.07.002711432116115693"}, {"Citation": "J. Y. Park, J. H. Kim, Y. M. Kim, H. J. Jeong, D. W. Kim, K. H. Park, H. J. Kwon, S. J. Park, W. S. Lee and Y. B. Ryu, Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases, Bioorg. Med. Chem. 20 (2012) 5928\u20135935; https://doi.org/10.1016/j.bmc.2012.07.03810.1016/j.bmc.2012.07.038712716922884354"}, {"Citation": "W. Luo, X. Su, S. Gong, Y. Qin, W. Liu, J. Li, H. Yu and Q. Xu, Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts, Biosci. Trends 3 (2009) 124\u2013126."}, {"Citation": "J. Y. Park, J. A. Ko, D. W. Kim, Y. M. Kim, H. J. Kwon, H. J. Jeong, C. Y. Kim, K. H. Park, W. S. Lee and Y. B. Ryu, Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV, J. Enzyme Inhib. Med. Chem. 31 (2016) 23\u201330; https://doi.org/10.3109/14756366.2014.100321510.3109/14756366.2014.100321525683083"}, {"Citation": "J. Y. Park, H. J. Yuk, H. W. Ryu, S. H. Lim, K. S. Kim, K. H. Park, Y. B. Ryu and W. S. Lee, Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors, J. Enzyme Inhib. Med. Chem. 32 (2017) 504\u2013515; http://doi.org/10.1080/14756366.2016.126551910.1080/14756366.2016.1265519601004628112000"}, {"Citation": "Y. B. Ryu, H. J. Jeong, J. H. Kim, Y. M. Kim, J. Y. Park, D. Kim, T. T. Nguyen, S. J. Park, J. S. Chang, K. H. Park, M. C. Rho and W. S. Lee, Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition, Bioorg. Med. Chem. 18 (2010) 7940\u20137947; https://doi.org/10.1016/j.bmc.2010.09.03510.1016/j.bmc.2010.09.035712630920934345"}, {"Citation": "D. W. Kim, K. H. Seo, M. J. Curtis-Long, K. Y. Oh, J. W. Oh, J. K. Cho, K. H. Lee and K. H. Park, Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia, J. Enzyme Inhib. Med. Chem. 29 (2014) 59\u201363; https://doi.org/10.3109/14756366.2012.75359110.3109/14756366.2012.75359123323951"}, {"Citation": "J.-Y. Park, H. J. Jeong, J. H. Kim, Y. M. Kim, S.-J. Park, D. Kim, K. H. Park, W. S. Lee and Y. B. Ryu, Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus, Biol. Pharm. Bull. 35 (2012) 2036\u20132042; https://doi.org/10.1248/bpb.b12-0062310.1248/bpb.b12-0062322971649"}, {"Citation": "B. Ryu, J. Park, M. Kim, Y. Lee, D. Seo, S. Chang, H. Park, C. Rho and S. Lee, SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii, Bioorg. Med. Chem. Lett. 20 (2010) 1873\u20131876; https://doi.org/10.1016/j.bmcl.2010.01.15210.1016/j.bmcl.2010.01.152"}, {"Citation": "C. N. Chen, C. P. Lin, K. K. Huang, W. C. Chen, H. P. Hsieh, P. H. Liang and J. T. Hsu, Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3\u2019-digallate (TF3), Evid. Based Complement. Alternat. Med. 2 (2005) 209\u2013215; https://doi.org/10.1093/ecam/neh08110.1093/ecam/neh081"}, {"Citation": "C. C. Wen, L. F. Shyur, J. T. Jan, P. H. Liang, C. J. Kuo, P. Arulselvan, J. B. Wu, S. C. Kuo and N. S. Yang, Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication, J. Tradit. Complement. Med. 1 (2011) 41\u201350; https://doi.org/10.1016/s2225-4110(16)30055-410.1016/S2225-4110(16)30055-4"}, {"Citation": "J. K. Cho, M. J. Curtis-Long, K. H. Lee, D. W. Kim, H. W. Ryu, H. J. Yuk and K. H. Park, Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa, Bioorg. Med. Chem. 21 (2013) 3051\u20133057; https://doi.org/10.1016/j.bmc.2013.03.02710.1016/j.bmc.2013.03.027"}, {"Citation": "G. W. Qin and R. S. Xu. Recent advances on bioactive natural products from Chinese medicinal plants, Med. Res. Rev. 18 (1998) 375\u2013382; https://doi.org/10.1002/(sici)1098-1128(199811)"}, {"Citation": "X. Wu, G. Qin, K. K. Cheung and K. F. Cheng, New alkaloids from Isatis indigotica, Tetrahedron 53 (1997) 13323\u201313328.10.1016/S0040-4020(97)00846-6"}, {"Citation": "C. Jie, Z. Luo, H. Chen, M. Wang, C. Yan, Z. F. Mao, G. K. Xiao, H. Kurihara, Y. F. Li and R. R. He, Indirubin, a bisindole alkaloid from Isatis indigotica, reduces H1N1 susceptibility in stressed mice by regulating MAVS signaling, Oncotarget 8 (2017) 105615\u2013105629; https://doi.org/10.18632/oncotarget.2235010.18632/oncotarget.22350573966429285277"}, {"Citation": "S. L. Hsuan, S. C. Chang, S. Y. Wang, T. L. Liao, T. T. Jong, M. S. Chien, W. C. Lee, S. S. Chen and J. W. Liao, The cytotoxicity to leukemia cells and antiviral effects of Isatis indigotica extracts on pseudorabies virus, J. Ethnopharmacol. 123 (2009) 61\u201367; https://doi.org/10.1016/j.jep.2009.02.02810.1016/j.jep.2009.02.028712679319429341"}, {"Citation": "M. Iranshahi, R. Rezaee, H. Parhiz, A. Roohbakhsh and F. Soltani, Protective effects of flavonoids against microbes and toxins: The cases of hesperidin and hesperetin, Life Sci. 137 (2015) 125\u2013132; https://doi.org/10.1016/j.lfs.2015.07.01410.1016/j.lfs.2015.07.01426188593"}, {"Citation": "T. N. Kaul, E. Middleton, Jr. and P. L. Ogra, Antiviral effect of flavonoids on human viruses, J. Med. Virol. 15 (1985) 71\u201379; https://doi.org/10.1002/jmv.189015011010.1002/jmv.18901501102981979"}, {"Citation": "W. S. Lee, J. R. Kim, J. M. Han, K. C. Jang, D. E. Sok and T. S. Jeong, Antioxidant activities of abietane diterpenoids isolated from Torreya nucifera leaves, J. Agric. Food Chem. 54 (2006) 5369\u20135374; https://doi.org/10.1021/jf060896c10.1021/jf060896c16848519"}, {"Citation": "K. Bae, The Medicinal Plants of Korea, Kyo-Hak Publishing Co., Seoul 2000, pp. 260."}, {"Citation": "J. Oh, H. S. Rho, Y. Yang, J. Y. Yoon, J. Lee, Y. D. Hong, H. C. Kim, S. S. Choi, T. W. Kim, S. S. Shin and J. Y. Cho, Extracellular signal-regulated kinase is a direct target of the anti-inflammatory compound amentoflavone derived from Torreya nucifera, Mediators Inflamm. 2013 (2013) Article ID 761506 (11 pages); https://doi.org/10.1155/2013/76150610.1155/2013/761506"}, {"Citation": "S. P. Chen, M. Dong, K. Kita, Q. W. Shi, B. Cong, W. Z. Guo, S. Sugaya, K. Sugita and N. Suzuki, Anti-proliferative and apoptosis-inducible activity of labdane and abietane diterpenoids from the pulp of Torreya nucifera in HeLa cells, Mol. Med. Rep. 3 (2010) 673\u2013678; https://doi.org/10.3892/mmr_0000031510.3892/mmr_00000315"}, {"Citation": "S. H. Kim, J. G. Park, Y. D. Hong, E. Kim, K. S. Baik, D. H. Yoon, S. Kim, M. N. Lee, H. S. Rho, S. S. Shin and J. Y. Cho, Src/Syk/IRAK1-targeted anti-inflammatory action of Torreya nucifera butanol fraction in lipopolysaccharide-activated RAW264.7 cells, J. Ethnopharmacol. 188 (2016) 167\u2013176; https://doi.org/10.1016/j.jep.2016.05.00810.1016/j.jep.2016.05.008"}, {"Citation": "P. G. Latha, D. A. Evans, K. R. Panikkar and K. K. Jayavardhanan, Immunomodulatory and antitumour properties of Psoralea corylifolia seeds, Fitoterapia 71 (2000) 223\u2013231; https://doi.org/10.1016/s0367-326x(99)00151-310.1016/S0367-326X(99)00151-3"}, {"Citation": "J. P. Kotiyal and D. P. Sharma, Phytochemical studies of Psoralea species, Bull. Medico-Ethnobot. Res. 13 (1992) 209\u2013223."}, {"Citation": "G. Jiangning, W. Xinchu, W. Hou, L. Qinghua and B. Kaishun, Antioxidants from a Chinese medicinal herb Psoralea corylifolia L., Food Chem. 91 (2005) 287\u2013292.10.1016/j.foodchem.2004.04.029"}, {"Citation": "G. Xiao, G. Li, L. Chen, Z. Zhang, J. J. Yin, T. Wu, Z. Cheng, X. Wei and Z. Wang, Isolation of antioxidants from Psoralea corylifolia fruits using high-speed counter-current chromatography guided by thin layer chromatography-antioxidant autographic assay, J. Chromatogr. A 1217 (2010) 5470\u20135476; https://doi.org/10.1016/j.chroma.2010.06.04110.1016/j.chroma.2010.06.04120663508"}, {"Citation": "S. Yin, C. Q. Fan, Y. Wang, L. Dong and J. M. Yue, Antibacterial prenylflavone derivatives from Psoralea corylifolia, and their structure-activity relationship study, Bioorg. Med. Chem. 12 (2004) 4387\u20134392; https://doi.org/10.1016/j.bmc.2004.06.01410.1016/j.bmc.2004.06.01415265490"}, {"Citation": "N. A. Khatune, M. E. Islam, M. E. Haque, P. Khondkar and M. M. Rahman, Antibacterial compounds from the seeds of Psoralea corylifolia, Fitoterapia 75 (2004) 228\u2013230; https://doi.org/10.1016/j.fitote.2003.12.01810.1016/j.fitote.2003.12.01815030932"}, {"Citation": "S. Chanda, M. Kaneria and R. Nair, Antibacterial activity of Psoralea corylifolia L. seed and aerial parts with various extraction methods, Res. J. Microbiol. 6 (2011) 124\u2013131; https://doi.org/10.3923/jm.2011.124.13"}, {"Citation": "C. H. Chen, T. L. Hwang, L. C. Chen, T. H. Chang, C. S. Wei and J. J. Chen, Isoflavones and anti--inflammatory constituents from the fruits of Psoralea corylifolia, Phytochemistry 143 (2017) 186\u2013193; https://doi.org/10.1016/j.phytochem.2017.08.00410.1016/j.phytochem.2017.08.00428825980"}, {"Citation": "L. T. Yi, Y. C. Li, Y. Pan, J. M. Li, Q. Xu, S. F. Mo, C. F. Qiao, F. X. Jiang, H. X. Xu, X. B. Lu, L. D. Kong and H. F. Kung, Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea corylifolia in the forced swimming test in mice, Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 510\u2013519; https://doi.org/10.1016/j.pnpbp.2007.10.00510.1016/j.pnpbp.2007.10.00518006202"}, {"Citation": "N. J. Sun, S. H. Woo, J. M. Cassady and R. M. Snapka, DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia, J. Nat. Prod. 61 (1998) 362\u2013366; https://doi.org/10.1021/np970488q10.1021/np970488q9544566"}, {"Citation": "C. Cheng, S. Yu-Feng, H. Yang, L. Lei, C. Wei-Chao, W. Gao-Xue and Z. Bin, Highly efficient inhibition of spring viraemia of carp virus replication in vitro mediated by bavachin, a major constituent of Psoralea corylifolia Lynn., Virus Res. 255 (2018) 24\u201335; https://doi.org/10.1016/j.virusres.2018.06.00210.1016/j.virusres.2018.06.00229913251"}, {"Citation": "C. Cabrera, R. Gim\u00e9nez and M. C. L\u00f3pez, Determination of tea components with antioxidant activity, J. Agric. Food Chem. 51 (2003) 4427\u20134435; https://doi.org/10.1021/jf030080110.1021/jf030080112848521"}, {"Citation": "M. Weerawatanakorn, W. L. Hung, M. H. Pan, S. Li, D. Li, X. Wan and C. T. Ho, Chemistry and health beneficial effects of oolong tea and theasinensins, Food Sci. Hum. Well. 4 (2015) 133\u2013146; https://doi.org/10.1016/J.FSHW.2015.10.00210.1016/j.fshw.2015.10.002"}, {"Citation": "W. C. Reygaert, The antimicrobial possibilities of green tea, Front. Microbiol. 5 (2014) Article ID 434 (8 pages); https://doi.org/10.3389/fmicb.2014.0043410.3389/fmicb.2014.00434413848625191312"}, {"Citation": "M. Friedman, Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas, Mol. Nutr. Food Res. 51 (2007) 116\u2013134; https://doi.org/10.1002/mnfr.20060017310.1002/mnfr.200600173716838617195249"}, {"Citation": "J. M. Song, K. H. Lee and B. L. Seong, Antiviral effect of catechins in green tea on influenza virus, Antiviral Res. 68 (2005) 66\u201374; https://doi.org/10.1016/j.antiviral.2005.06.01010.1016/j.antiviral.2005.06.01016137775"}, {"Citation": "Z. F. Yang, L. P. Bai, W. B. Huang, X. Z. Li, S. S. Zhao, N. S. Zhong and Z. H. Jiang, Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure-activity relationship analysis, Fitoterapia 93 (2014) 47\u201353; https://doi.org/10.1016/j.fitote.2013.12.01110.1016/j.fitote.2013.12.01124370660"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2021", "Month": "9", "Day": "14"}, {"Year": "2023", "Month": "1", "Day": "18", "Hour": "7", "Minute": "2"}, {"Year": "2021", "Month": "12", "Day": "30", "Hour": "0", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "20", "Hour": "6", "Minute": "0"}], "PublicationStatus": "epublish", "ArticleIdList": ["36651508", "10.2478/acph-2022-0021", "acph-2022-0021"]}}], "PubmedBookArticle": []}